GS
RDHL

Gagnon Securities’s Redhill Biopharma RDHL Stock Holding History

Gagnon Securities’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.7K Hold
88,405
– – 0.01% 83
2026
Q1 		$65.9K Buy
88,405
+2,303
+3% +$2.43K 0.02% 85
2025
Q4 		$88.7K Buy
86,102
+68,280
+383% +$91.8K 0.02% 86
2025
Q3 		$38.7K Buy
+17,822
New +$29K 0.01% 86
2024
Q3 		– Sell
-4,641
Closed -$43K – 103
2024
Q2 		$43K Sell
4,641
-93
-2% -$1.03K 0.01% 96
2024
Q1 		$62.7K Buy
4,734
+1,150
+32% +$20.5K 0.01% 94
2023
Q4 		$131K Buy
3,584
+1,665
+87% +$34K 0.03% 96
2023
Q3 		$24.5K Buy
+1,919
New +$50.2K 0.01% 96
2023
Q1 		– Sell
-332
Closed -$46.6K – 114
2022
Q4 		$46.6K Sell
332
-54
-14% -$23.4K 0.01% 103
2022
Q3 		$194K Buy
386
+11
+3% +$9.58K 0.04% 91
2022
Q2 		$327K Buy
375
+8
+2% +$11K 0.07% 82
2022
Q1 		$926K Buy
367
+49
+15% +$116K 0.15% 58
2021
Q4 		$821K Sell
318
-74
-19% -$296K 0.12% 58
2021
Q3 		$1.8M Buy
392
+49
+14% +$332K 0.27% 46
2021
Q2 		$2.36M Buy
343
+11
+3% +$75.9K 0.33% 44
2021
Q1 		$2.43M Buy
332
+51
+18% +$428K 0.37% 45
2020
Q4 		$2.27M Buy
281
+43
+18% +$387K 0.36% 45
2020
Q3 		$2.43M Buy
238
+28
+13% +$230K 0.52% 38
2020
Q2 		$1.41M Buy
210
+111
+112% +$764K 0.34% 43
2020
Q1 		$449K Sell
99
-14
-12% -$70K 0.15% 50
2019
Q4 		$683K Buy
+113
New +$722K 0.15% 56

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return

Gagnon Securities's RDHL Position: Q2 2026 in Review

Gagnon Securities held its Redhill Biopharma (RDHL) position steady in Q2 2026 at 88,405 shares worth $74.7K. The position accounts for 0.01% of the portfolio, ranked #83.

Gagnon Securities first reported a position in RDHL in Q4 2019 and has held it in 21 quarters since. The position peaked at $2.43M in Q3 2020. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • Gagnon Securities held 88,405 shares of Redhill Biopharma worth $74.7K as of Q2 2026.
  • Gagnon Securities left its Redhill Biopharma share count unchanged in Q2 2026.
  • Redhill Biopharma made up 0.01% of Gagnon Securities's portfolio in Q2 2026, its #83 holding.
  • Gagnon Securities first reported a position in Redhill Biopharma in Q4 2019 and has held it in 21 quarters since.
  • Gagnon Securities's Redhill Biopharma position peaked at $2.43M in Q3 2020.
  • 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on Gagnon Securities's 13F filing for Q2 2026, filed 5 Aug 2026.